DRAGARWQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Agarwal's Eye Hospital has issued a corrigendum to its 31st AGM notice (scheduled for September 24, 2025) at the request of BSE, to provide clarifications on a proposed preferential issue of 1,32,827 equity shares. The shares will be allotted to promoter Dr. Agarwal's Health Care Limited at ₹5,270 per share, raising approximately ₹70 crores. Of the proceeds, ₹60 crores will fund the reconstruction of the flagship Chennai Main Hospital (project cost revised from ₹70 crores to ₹164 crores) and ₹9.99 crores will go toward general corporate purposes. Post-issue, promoter holding will rise slightly from 71.9% to 72.67%, while public shareholding will dilute from 28.1% to 27.33%. The corrigendum has been sent to shareholders electronically and will be published in Financial Express and Makkal Kural newspapers.
The preferential allotment to the promoter signals continued promoter commitment and funding support for the strategic Chennai hospital rebuild, though it causes marginal dilution for public shareholders. Shareholders should review the revised AGM notice before voting on this special resolution at the September 24 meeting.